Introduction
Breast tumors arise in a parenchymal tissue which at the sub-gross level has an organized, three-dimensional structure and at the cellular level consists of a very restricted number of discrete cell types (1) . The normal human breast in mature, non-pregnant women consists of branching systems of ducts that normally terminate in lobules of variable numbers of budslductules (2,3). During the first few months of pregnancy there is a marked increase in large clusters of ductules which become distended and form secretory alveoli during the lactational phase (4.5). Most breast tumors are thought to originate within the terminal structures, possibly at the interface of terminal duct and lobule, although there are exceptions (2) . The ducts and ductules usually consist of two cell types, an inner lining of epithelial cells and an outer, sometimes discontinuous, lining of myoepithelial cells. Both structures are separated from the stroma by a basement membrane (6) . A third cell type that lines distended ductules or alveoli during pregnancy and lactation, the alveolar cell, is responsible for the production of milk (7) . The cellular origin(s) of breast tumors is unclear, although morphological and ultrastructural analyses suggest that benign tumors involve proliferation of the ductularlductal unit, whereas most invasive carcinomas probably develop by proliferation of the lining epithelial cells within these units, first in situ and then external to the normal structures in invasive carcinomas (7, 8) .
Morphological criteria and topographical relationships alone are inadequate when attempts are made to relate the organization and differentiation of the normal breast to cell structures observed in breast tumors. More recently, limited studies with single immunocytochemical stains for myoepithelial (9) (10) (11) (12) (13) or secretory alveolar cells (1415) have broadly confirmed the absence of myoepithelial and secretory alveolar cells in invasive ductal and lobular carcinoma of the breast, although there have been exceptions in both instances (16) (17) (18) . However, the variation in cell expression of some of the antigenic markers for either cell type with location and differentiation within the normal parenchyma of the breast, particularly those based on keratins for the myoepithelial cell (19) , may have reduced the significance of immunocytochemical results based on the use of a single antigenic marker for a specific cell type. In this study, multiple antigenic markers for all three types of breast cell were utilized on the same set of samples from different benign and malignant diseases of the breast. Thus, antiserum to epithelial membrane antigen (EMA) (20) . monoclonal antibodies (MAb) to human milk-fat globule membranes (MFGM) (21) , and MAb to cytokeratin 18 (22) were used to locate epithelial cells. Antibodies to smooth muscle actin (9) . vimentin (19) and the associated basement membrane proteins laminin and Type IV collagen (10,23) were used to locate myoepithelial cells, and antibodies to Band K-caseins (24) were used to locate secretory alveolar cells. In addition, keratin antibodies that preferentially stain myoepithelial cells in main ducts but that stain luminal epithelial cells in growing structures of the breast (19, 25) were also utilized. The multiple staining patterns for the different breast tumors are related to the different cell types in the normal breast.
Materials and Methods
Tissues and Tumors. Normal breast tissues from reduction mammoplasties of nulliparous, pre-menopausal women and from pregnant women were obtained as described previously (19) . Breast lesions and primary tumors were obtained at surgery from Arrowe Park and the Royal Liverpool Hospitals and the patients' ages and menstrual status were recorded. The ratio of benign to malignant disease in unselected patients was 5.4:l. Tissues and tumors were cut into 1-cm cubes and the cubes fmed in Methacarn [60% methanol, 30% Inhibisol (BDH Chemicals; Speke, Liverpool, UK), 10% acetic acid] for 24 hr (26) . stored in 70% ethanol, processed, and embedded in paraffin as described previously (27) . The cutting up of the tissue into cubes allows better penetration of the fixatives and the use of Methacarn over formalin preserves better cell detail and produces enhanced staining with many of the antibodies (10J9.26). Serial wax-embedded sections were cut at 2 pm and processed as before (26) ; the pathological diagnosis was made from near adjacent, hematoxylin-and eosin-stained sections, according to standard criteria (28) . In controls, some of the cubes of tumor were frozen in isopentane, stored in liquid nitrogen, and serial frozen sections were cut at 6 pm, air-dried for 2 hr, and fixed in chloroformacetone (l:l, v/v) for 5 min at 4°C (19) .
Antibodies. Rabbit anti-EMA (20) , anti-mouse laminin, anti-mouse Type IV collagen, anti-human callus keratin (the major components being of molecular weights 69, 57,47 and 43 KD) (26) , anti-smooth muscle actin, and anti-hamster fibroblast vimentin (19) have been described previously. Antisera to laminin, Type IV collagen, and keratin were affinity-purified before use. Purified immunoglobulin G (IgG) fractions were obtained from the other antisera by chromatography on DEAE-Affi-Gel blue (BioRad Laboratories; Watford, UK). Mouse MAb LICR-LON-M8, M18, and M24 raised against defatted human milk-fat globular membrane (21) recognized EMA (M8) (29) , Gal(l+4)GlcNAcfl(1-+6) (M18) (30) , or the sugar residue(s) of MFGM glycoproteins and glycolipids (M24) (31) . They were used as a cocktail in equal proportions (19) . Mouse MAb LP34 (22) . PKK2, and PKK3 (19, reactive against keratins 4, 5 , 6, 10, 18, keratins 7, 16, 17, 19 , and keratin 18, respectively, were a gift from Dr. J. liylor-Papadimitriou (ICE, (24) . The debris was removed by centrifugation before use. Antibodies absorbed in this way yielded no visible immunocytochemical staining on test sections of human breasts at 100 times the normal concentration of antibodies used J.m"ocytochemical Staining. For antisera and MAb to keratin, vimentin, Type IV collagen, and laminin, sections were pre-treated with Pronase (Calbiochem; La Jolla, CA) as described previously (26) . This procedure is required whether Methacarn or formalin is used as the fixative (26) . For all antibodies, immunocytochemical staining was carried out by an indirect procedure using either alkaline phosphatase-conjugated (rabbit antisera) (26) or peroxidase-conjugated (mouse MAb) (19) second antibodies, depending on which gave the lower nonspecific staining; the sections were pre-incubated with acetic acid or phenylhydrazine-HC1, respectively, to inhibit endogenous enzymic activities. The colors were developed by incuba-tion either with naphthol dyes or with oxidized diaminobenzidine, respectively. All sections were counterstained with the nuclear stain Mayer's hemalum. Sections were observed in a Reichert Polyvar microscope and photographed through a Kodak Wratten No. 44 filter.
The specificity of staining for each antibody was checked by the following controls. (a) Complete abolition of immunocytochemical staining was achieved by prior incubation of each antibody with the immunizing antigen (33). (b) Results of staining by the different antibodies were the same for tissues preserved in Methacarn or in formol-saline, but those tissues fixed in Methacarn gave the most intense staining (19) . Results for some tumors were also confirmed by staining unfixed frozen sections, although such sections were more distorted than those for tumors preserved in fixatives. (c) Control sections from the mammoplasties of nulliparous women or from breasts of pregnant women were stained in parallel with each antibody, and the overall results were rejected if the controls did not conform to results described previously (19). (d) Two sections from each lesion were stained and examined for each antibody and the average result was recorded; at least 10 typical structures/areas of the same type were examined for each lesion. The average proportion of inner cuboidal and peripheral cells that were stained was recorded. The type and number of breast lesions examined are shown in Table 2 .
Results
Immunocytochemical staining results for benign hyperplasias and neoplasias in the breast were similar and could be summarized as one group, except where discussed separately. Similarly staining results for the different histological types of carcinoma showed little variation and could be summarized as another group. Both groups of tumors were further subgrouped into those from premenopausal and post-menopausal women but, except where explicitly stated, there were no differences between these two subgroups. The staining patterns have been described in terms of markers related to the different cell types of the normal breast.
Immunocytochemical Staining for Epithelial Marhers
Antiserum to EMA or the MAb M8, M18, and M24 stained approximately 50-80% of the inner cells in main ducts, 70-90% of the inner cells in benign lesions (Figures la-le), and 40-70% of the inner cells in carcinoma in situ ( Figure If ) and in invasive carcinomas ( Figures Ig and 1h ; Table 3 ). The combination of MAb to MFGM stained between 10% and 20% fewer cells than the anti-EMA serum, even when the concentration of MAb was increased a hundredfold (not shown). In benign lesions (Table 2) , abnormal duct-like ( Figure la ) and alveolar bud-like structures ( Figure Ib ) contained multiple layers of inner cells that were predominantly cuboidal in form. These inner cells surrounded lumina and were stained intensely. In addition, peripheral cells were observed that were more elongated in form, and these stained weakly; they were often discontinuous in the alveolar bud-like structures. The inner cells were stained mainly at their peripheries and, where adjacent to lumina, their apical surfaces were often stained preferentially ( Table 3 ). The majority (80-90%) of the invasive carcinomas fell into the less-well-stained category containing 2 0 4 0 % of stained cells. In benign lesions and in carcinoka in situ, the peripheral cell layer was unstained, whereas in invasive carcinomas the peripheral cell layer assumed the morphology and staining characteristics of the inner cells. In the end bud-like structures there was a gradation in staining for keratin 18 from a maximum at their centers to a minimum at their peripheries ( Figure 2b ). (Inset) This is shown more clearly. (g) Invasive ductal carcinoma stained with MAb ME, M18. and M24. Most carcinoma cells are stained intensely both within their cytoplasm and at their peripheries(arrows). the remaining carcinoma cells are stained more weakly or not at all. There is no difference in staining pattern or morphology between the peripheral cells and the inner cells. ( Figure 3d ). The inner cells were unstained. The staining for actin in the peripheral cells was weakest at the distal tip of the ductular structures ( Figure 3a ) and most prominent in areas of sclerosing adenosis (Figure 3b ). In all cases of staining for actin in benign tumors ( Table 2) . the peripheral cells were a component of these tumors. In contrast in carcinoma in situ, the attenuated peripheral cells were of host origin (Figure 3c ), probably myoepithelial cells.
Immunocytochemical Staining for Myoepithelium-related Marhers
Antiserum and MAb to vimentin stained 50-70% of periph-era1 cells in main ducts, stained weakly to moderately 60-70% of peripheral cells in benign lesions (Figures 3e and 3f ), and stained strongly 60-70% of the peripheral cells in carcinoma in situ, but failed to stain peripheral cells in invasive carcinomas (Figure 3g ). The inner cells were unstained. 1n.benign lesions the ductules contained moderately to strongly stained peripheral cells, particularly in sclerosing adenosis (Figure 3e ), whereas neoplastic bud-like structures possessed peripheral cells that were stained only weakly with antibodies to vimentin (Figure 3f ). Invasive carcinomas, particu-larly of the ductal type (Table 2) , contained non-neoplastic spindle cells of the host that were stained with antibodies to smooth muscle actin and vimentin (Figure 3h ). That failure of the tumor cells of the carcinomas to stain with antibodies to actin or vimentin was due to interference with the immunocytochemical reactions was excluded by the presence of stained blood vessels on the same histological sections (Figures 3d and 3g) . , Antibodies to Type IV collagen and ..minin delineated ' ...e basement membrane that completely encircled all forms of benign lesions (Figures 4a and 4b ) and carcinoma in situ (Figure 4c ) but was largely lost in 90-95% of invasive carcinomas (Figure 4d ; Table 3 ). In the bud-like structures in benign lesions, the stained basement membrane was thinnest at the distal tips and increased in thickness until it reached the thickness of that of the subtending duct-like structures (Figure 4a ). Under such conditions cytoplasmic staining of peripheral cells was occasionally observed ( Figure  4b) , particularly in areas of sclerosing adenosis.
Immunocytochemical Staining for Marhers Associated with Both Epithelial and Myoepithelial Cells
Keratin MAb PKK2 stained 50-70% of peripheral myoepithelial cells but only 5-10% of inner epithelial cells in main ducts (Table  3 ). In benign lesions the same MAb strongly stained 5 0 4 0 % of inner cells (Figures 5a-5d ) but only 5-10% of the pleomorphic cells in carcinoma in situ (Figure 5e ) or in invasive carcinomas ( Figure  5f ). The peripheral cells were very occasionally stained intensely (<5%) in benign lesions and in invasive carcinomas, but the majority of the peripheral cells of the host were stained intensely in carcinoma in situ ( Figure Se ; Table 3 ). Carcinoma cells, however, could be stained weakly; most invasive carcinomas contained 10-20% of such stained cells. All structures observed in benign and malignant conditions ( Table 2) broadly followed this pattern, including cystic expansion of ducts/ductules (Figures 5a and 5b) . adenosis (Figure 5a ), and epitheliosis. in which growing end bud-like structures ( Figure 5c ) were observed, as well as lobular and ductal carcinoma in situ and invasive carcinomas. Sometimes, where atypical cell proliferations occurred in epitheliosis and gave rise to multilayer-549 ing of inner cells, the staining oL ;uch cells with MAb PKK2 was variable, with some cells stained intensely and others not stained at all (Figure 5d ).
Pankeratin MAb LP34 strongly stained 50-70% of the peripheral myoepithelial cells and 5-10% of the inner epithelial cells in main ducts; the remaining epithelial cells were stained weakly ( Table 3 ). However, this MAb strongly stained 70-90% of the inner cells in all forms of benign breast lesions, but only WO% of inner cells in carcinoma in situ, and invasive carcinomas were stained strongly, with another 10-20% of such cells stained weakly. The peripheral cells were either weakly stained or unstained in benign lesions and invasive carcinomas, but carcinoma in situ contained strongly staining, attenuated host cells surrounding the cords of malignant cells (Table 3) . Similar results for benign and malignant disease were observed with the pan-keratin rabbit antiserum ( Table 3 ). To eliminate the possibility that the lack of staining of infiltrating carcinomas with any of MAb PKK2. LP34, or anti-keratin serum was due to a simple artifact, such areas were still found to be unstained even when adjacent to strongly stained areas of benign disease (Figure 5g ). Moreover, in most primary invasive ductal carcinomas that were largely unstained by these three antikeratins, areas of carcinoma in situ and invasive carcinoma were present which contained both stained and unstained malignant cells, although the unstained variety usually dominated the bulk of the tumor (Figure 5h ).
Immunocytochemical Staining for Secretory Alveolar Cells
MAb to human K-casein (MAb 14.1) and p-casein (MAb 32.2) failed to stain any cells in breasts of nulliparous females but stained 70-80% of cells in 16-week pregnant glands. The majority of benign lesions in patients with unstimulated breasts failed to be stained with either MAb. but 5-10% of lesions contained 0.1-5% of the total cells that were stained by either one of the MAb, predominantly in areas of adenosis (Figure 6a ). The benign lesions in both 16-to 18-week pregnant patients contained 50-70% of cells that were stained forb-and K-casein either in areas of adenosis ( Figure   6b ) or in lactating adenomatous regions (Figure 6c ). Staining for caseins was considerably reduced or absent in areas of cystic expansion and apocrine metaplasia, and was completely absent from areas of sclerosing adenosis. Carcinoma in situ and invasive carcinomas were not stained by either antibody ( Table 4 ). This was also true for the carcinomas from two patients who were also 15-19 weeks pregnant (Figure 6d ), although band K-CaseinS were readily de- (Figures 6b and 6c ). Any immunocytochemical staining with either casein MAb was located within the cytoplasm of the inner cells and within the lumina.
Discussion
The staining with monoclonal and polyclonal antibodies to EMA of inner cells in the benign and malignant lesions identifies them as the epithelial cells (20,34). Thus, epithelial cells can be identified in all benign and malignant breast diseases described in this study. The menopausal status and the age of the patients produced no significant differences in the percentages of stained cells, unlike an earlier study in the normal breast (25). This was probably due to the fact that all patients were cycling and none were prepubescent. The possibility that our results have been obtained from an unrepresentative population of patients with breast cancer is unlikely. Our samples were drawn from two large, primary referral hospitals. The proportion of benign to malignant disease in unselected patients of 5.4:l (see Materials and Methods) is close to the national average of 4.5:l (35) and does not reflect the proportion of 0.9:l of a specialist referral center (10). Moreover, the low proportion of carcinoma in situ and invasive tubular carcinoma does not reflect those drawn from a screened population (36) .
In the past, the presence (37) and absence (8) of myoepithelial cells in invasive carcinomas of the breast has been reported by use of histological identification at the light and electron microscopic levels, although their presence in benign lesions and as the uninvolved peripheral cells of ducts/ductules that encircle carcinoma in situ is well established (8.28). This discrepancy in invasive carcinomas of the breast has been suggested to be due to confusion of tonofilaments in epithelial cells with myofilaments in myoepithelial cells (38) . In our study, staining for smooth muscle actin and vimentin was observed in all types of benign breast lesions ex- amined, both hyperplastic and neoplastic, and was absent from all histological types of invasive breast carcinomas examined, including tubular carcinoma.
As with the myoepithelial cell, the presence or absence of the secretory alveolar cell in invasive breast carcinomas has been disputed in the past using immunological detection for caseins and a-lactalbumin (16, (39) (40) (41) (42) . In this study, the use of highly specific MAb to human Pand K-caseins has shown for all histological types of invasive carcinoma examined, including tubular carcinoma, that they fail to stain for Pand K-caseins. However, these caseins are detected immunocytochemically only in the normal breasts of women in late pregnancy and during lactation (14, 15) , and hence can be expected to occur only in breast tumors in women in a similar hormonal state. Here we have also shown that pand K-caseins can be detected immunocytochemically in benign lesions but not in invasive carcinomas, in women in a hormonal state conducive to lactation. This result probably reflects the ability of benign lesions, but not invasive carcinomas to produce secretory alveolar cells.
The most surprising results are those obtained with the keratin MAb PKK3, PKK2, and LP34. In our study there is a preponderance of immunocytochemical staining for keratin 18 in the majority of the benign lesions of the breast. The extent of staining, although highly variable, is usually reduced in invasive carcinoma, independent of the histological types examined. In our study MAb PKKZ and LP34 preferentially stain the inner epithelial cells over the peripheral cells in the benign lesions. This result is in contrast to that observed in ducts of the normal resting breast (19) but is reminiscent of that in growing terminal ducts and end budslductules (25), perhaps suggesting their origins. In our study, MAb PKK2 and LP34 fail to stain most carcinomas, perhaps suggesting a different origin from that of the benign lesions. However, in the relatively few cases of invasive ductal carcinomas that have been examined in detail in this study, PKKZ-stained malignant cells can be observed in carcinoma in situ and close by in areas of invasive carcinoma, whereas they are absent from the remaining carcinomatous areas. These results suggest selective loss of expression of the keratins recognized by MAb PKKZ in invasive carcinomas.
In agreement with earlier results (10, 23, 43) , our study shows that some epithelial cells in invasive breast carcinomas also express laminin and Type IV collagen, components of the basement membrane, although these are of a more irregular and limited nature. Therefore, there is not a sharp cut-off in production of such components between benign and malignant lesions, and the presence of basement membrane components may reflect a limited but incomplete differentiation towards the myoepithelial cell (44) . In conclusion, our results are consistent with the presence of both myoepithelial and secretory alveolar cells in benign lesions and tumors of the breast, although complete generation of the latter cell type requires a similar hormonal environment to that in normal late-pregnant/lactating females. In contrast, most areas of invasive carcinomas do not contain definitive markers characteristic of myoepithelial cells (smooth muscle actin, vimentin) or of secretory alveolar cells (caseins).
